| h-debate-bd37eafbc00 | Astrocyte Metabolic Reprogramming Therapy | 0.00 | 0.55 | Multiple | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v2-20260402032945 |
| h-debate-f3f40ca6614 | Neuronal MAPT-Vulnerability Stratified Therapy | 0.00 | 0.55 | MAPT | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v2-20260402032945 |
| h-debate-7c931dcbc5d | Selective SYK Inhibition for Neuroprotective Microglia | 0.00 | 0.55 | SYK | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v2-20260402032945 |
| h-debate-19532f799d5 | TIM-3 Checkpoint Modulation in Microglia | 0.00 | 0.55 | HAVCR2 | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v2-20260402032945 |
| h-debate-669d93190fe | NF-κB/β-Catenin Competitive Binding Modulation | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-6adbfa431d7 | Sepsis-Associated Encephalopathy Prevention via Early BBB Stabilization | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-b23031e2aee | Endocannabinoid-Mediated Tight Junction Stabilization | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-34efaec3c6a | Microglial-Endothelial Cross-Talk Disruption Therapy | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-90260a5f8a4 | Perivascular Cell Reprogramming via CREB Inhibition | 0.00 | 0.55 | CREB1 | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-7974c5174f2 | Epigenetic Silencing of SPP1 in Disease-Associated Microglia | 0.00 | 0.55 | HDAC1 | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-fdeb17bb2db | Early Immune Challenge Tolerance Induction | 0.00 | 0.55 | IL10 | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-854c27f7826 | Immune Checkpoint Modulation via TREM2 | 0.00 | 0.55 | TREM2 | proposed | 2026-04-29 | SDA-2026-04-06-gap-001 |
| h-debate-db1d8d09a38 | Anti-Fibrotic TREM2 Antagonism for Chronic Neuroinflammation | 0.00 | 0.55 | TREM2 | proposed | 2026-04-29 | SDA-2026-04-06-gap-001 |
| h-debate-49950d30b55 | Tissue-Specific TREM2 Targeting Strategy | 0.00 | 0.55 | TREM2 | proposed | 2026-04-29 | SDA-2026-04-06-gap-001 |
| h-debate-5f3fb97877f | Cardiac-Inspired Neuroprotective TREM2hi Strategy | 0.00 | 0.55 | TREM2 | proposed | 2026-04-29 | SDA-2026-04-06-gap-001 |
| h-debate-24496b9f55b | Astrocyte Subtype-Specific Anti-Inflammatory Reprogramming | 0.00 | 0.55 | C3 | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v3-20260402063622 |
| h-debate-5a9daed37b1 | Layer-Specific Interneuron Protection in Deep Cortical Layers | 0.00 | 0.55 | PVALB | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v3-20260402063622 |
| h-debate-23a6e5164ff | Oligodendrocyte Precursor Cell Activation for Remyelination | 0.00 | 0.55 | PDGFRA | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v3-20260402063622 |
| h-debate-9445b5b09ce | BIN1 Neuronal Isoform Restoration in Vulnerable Excitatory Neurons | 0.00 | 0.55 | BIN1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-v3-20260402063622 |
| h-debate-d109f2d3c99 | Syndecan-Mediated Uptake Inhibition | 0.00 | 0.55 | SDC4 | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-09e85748b02 | BIN1-Targeted Extracellular Vesicle Trafficking Disruption | 0.00 | 0.55 | BIN1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-810ad6b712e | Heparan Sulfate 3-O-Sulfation Modulators | 0.00 | 0.55 | HS3ST1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-12009b968f7 | Lysosomal Membrane Stabilization to Prevent Tau Seeding | 0.00 | 0.55 | LAMP1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-d0dc5412596 | Cathepsin D Enhancement for Tau Degradation | 0.00 | 0.55 | CTSD | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-bf566d9f6f8 | TREM2 Agonist Therapy to Redirect Microglial Exosome Content | 0.00 | 0.55 | TREM2 | proposed | 2026-04-29 | SDA-2026-04-03-gap-tau-prop-20260402003221 |
| h-debate-5e1dc36a912 | Cross-Cell Type Communication Restoration | 0.00 | 0.55 | Multiple | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-20260402025452 |
| h-debate-1c57aa4321a | Myelin Interface Restoration Therapy | 0.00 | 0.55 | OLIG2 | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-20260402025452 |
| h-debate-cfd264781c9 | APOE4-Microglial Lipid Metabolism Correction | 0.00 | 0.55 | PICALM | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-20260402025452 |
| h-debate-7db304c9a9d | CD33-Sialic Acid Pathway Modulation in Microglia | 0.00 | 0.55 | CD33 | proposed | 2026-04-29 | SDA-2026-04-03-gap-seaad-20260402025452 |
| h-debate-118fe40083b | HDAC/MITF Epigenetic Reprogramming of Microglia | 0.00 | 0.55 | HDAC1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-c298c021dde | CX3CR1-Targeted Regulatory T Cell Homing | 0.00 | 0.55 | CX3CR1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-a90fddb8d4a | Galectin-3/TREM2 Competitive Inhibition Therapy | 0.00 | 0.55 | LGALS3 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-09095fc7bdb | Dual Astrocyte-Microglia Phenotype Synchronization | 0.00 | 0.55 | STAT3 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-5e8aa240b6e | Complement C3/C3aR Synaptic Protection Therapy | 0.00 | 0.55 | C3AR1 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-d2fcc106067 | MiT-TFE/LRRK2 Lysosomal Enhancement Therapy | 0.00 | 0.55 | LRRK2 | proposed | 2026-04-29 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-debate-d44f916a935 | Astrocyte Metabolic State Biosensor Therapy | 0.00 | 0.55 | Engineered FRET sensors | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-e6a431dd |
| h-debate-1701b22cd72 | Astrocyte Fuel Preference Pharmacogenomics | 0.00 | 0.55 | HMGCS2 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-e6a431dd |
| h-debate-4f356011b8e | Neuron-Astrocyte Metabolic Mismatch Syndrome | 0.00 | 0.55 | SLC16A7 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-e6a431dd |
| h-debate-4e350771f27 | Mitochondrial Coupling Restoration Therapy | 0.00 | 0.55 | PPARGC1A | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-e6a431dd |
| h-debate-85c1a0f0180 | Ethnicity-Tailored Autophagy Enhancement | 0.00 | 0.55 | ATG7, ATG5, MTOR, TFEB | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-e6cda06abea | Population-Stratified Blood-Brain Barrier Engineering | 0.00 | 0.55 | ABCB1, ABCC1, CLDN5, OCLN | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-b0363863140 | Population-Stratified Estrogen Receptor Modulation | 0.00 | 0.55 | ESR1, ESR2, CYP19A1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-c97cafd2df9 | Ancestry-Specific Complement System Calibration | 0.00 | 0.55 | C1QA, C1QB, C1QC, C3 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-87ccee82a7d | Metabolic Reprogramming via Population-Adapted APOE Variants | 0.00 | 0.55 | APOE, PPARA, PPARG | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-9069dde94d9 | Population-Specific Synaptic Pruning Modulation | 0.00 | 0.55 | TREM2, CD33, CX3CR1, P2RY12 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222549-20260402 |
| h-debate-f96ba83ab6e | Synaptic Glucose Transporter Density as an Early Response Biomarker | 0.00 | 0.55 | SLC2A3, SNAP25 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-c698b06a |
| h-debate-b5cb6de2735 | Sex-Specific Metabolic Biomarker Panels for Alzheimer's Therapeutic Response | 0.00 | 0.55 | PPARGC1A, ESR1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-c698b06a |
| h-debate-cceb703815a | Multi-Modal Metabolic Connectivity Index for Disease Progression Monitoring | 0.00 | 0.55 | COMT, ATP synthase subunits | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222618-c698b06a |
| h-debate-35b63d336e6 | Synaptic Activity-Dependent Protection System | 0.00 | 0.55 | ARC | proposed | 2026-04-29 | sda-2026-04-01-gap-v2-691b42f1 |
| h-debate-5fbc939d943 | Temporal Modulation of Microglial Circadian Rhythms | 0.00 | 0.55 | CLOCK | proposed | 2026-04-29 | sda-2026-04-01-gap-v2-691b42f1 |